Rilei Jiang

559 total citations
15 papers, 391 citations indexed

About

Rilei Jiang is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Rilei Jiang has authored 15 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Rilei Jiang's work include MicroRNA in disease regulation (4 papers), Cancer-related molecular mechanisms research (3 papers) and Cancer Mechanisms and Therapy (2 papers). Rilei Jiang is often cited by papers focused on MicroRNA in disease regulation (4 papers), Cancer-related molecular mechanisms research (3 papers) and Cancer Mechanisms and Therapy (2 papers). Rilei Jiang collaborates with scholars based in China, Malaysia and United States. Rilei Jiang's co-authors include Xu Zhang, Meijuan Chen, Cheng Hu, Mianhua Wu, Zhan Zhan, Zhongping Wu, Xiaojia Zhu, Jiang Fengrong, Jiang Wu and Yichang Liu and has published in prestigious journals such as PLoS ONE, Frontiers in Pharmacology and BMC Cancer.

In The Last Decade

Rilei Jiang

15 papers receiving 387 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rilei Jiang China 12 211 136 55 49 46 15 391
Dongfeng Guo China 10 250 1.2× 127 0.9× 47 0.9× 49 1.0× 10 0.2× 15 417
Md Zakir Hossain Bangladesh 8 119 0.6× 35 0.3× 35 0.6× 39 0.8× 69 1.5× 24 355
Maryam Radinmanesh Iran 5 85 0.4× 59 0.4× 14 0.3× 32 0.7× 64 1.4× 10 312
Xiaoyan Cheng China 17 177 0.8× 61 0.4× 21 0.4× 11 0.2× 66 1.4× 45 698
Jiayi Gu China 10 126 0.6× 61 0.4× 17 0.3× 13 0.3× 46 1.0× 30 342
Jie Ding China 12 155 0.7× 63 0.5× 10 0.2× 9 0.2× 19 0.4× 48 591
Yu He China 11 150 0.7× 43 0.3× 12 0.2× 12 0.2× 169 3.7× 41 438
Randy J. Levitt Canada 8 126 0.6× 82 0.6× 8 0.1× 116 2.4× 64 1.4× 8 521
Jianchao Liu China 11 86 0.4× 40 0.3× 15 0.3× 17 0.3× 42 0.9× 32 270

Countries citing papers authored by Rilei Jiang

Since Specialization
Citations

This map shows the geographic impact of Rilei Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rilei Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rilei Jiang more than expected).

Fields of papers citing papers by Rilei Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rilei Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rilei Jiang. The network helps show where Rilei Jiang may publish in the future.

Co-authorship network of co-authors of Rilei Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Rilei Jiang. A scholar is included among the top collaborators of Rilei Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rilei Jiang. Rilei Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Zhou, Ting, et al.. (2025). Gut microbiota modulation by Traditional Chinese Medicine: a translational strategy for metabolic dysfunction-associated steatotic liver disease. Frontiers in Pharmacology. 16. 1600439–1600439. 1 indexed citations
2.
Li, Qian, et al.. (2024). Circular RNA-mediated miRNA sponge & RNA binding protein in biological modulation of breast cancer. Non-coding RNA Research. 9(1). 262–276. 20 indexed citations
3.
4.
Jiang, Rilei, et al.. (2023). The sodium new houttuyfonate suppresses NSCLC via activating pyroptosis through TCONS‐14036/miR‐1228‐5p/PRKCDBP pathway. Cell Proliferation. 56(7). e13402–e13402. 8 indexed citations
5.
Chen, Xiaolei, Hua Chen, Qian Li, et al.. (2022). Demethoxycurcumin mitigates inflammatory responses in lumbar disc herniation via MAPK and NF-κB pathways in vivo and in vitro. International Immunopharmacology. 108. 108914–108914. 11 indexed citations
6.
Zhang, Yujia, Sau Har Lee, Rui Zeng, et al.. (2022). Epiregulin increases stemness-associated genes expression and promotes chemoresistance of non-small cell lung cancer via ERK signaling. Stem Cell Research & Therapy. 13(1). 197–197. 11 indexed citations
7.
Li, Hua, Sau Har Lee, Rilei Jiang, et al.. (2022). Association of CYP24A1 with survival and drug resistance in clinical cancer patients: a meta-analysis. BMC Cancer. 22(1). 1317–1317. 10 indexed citations
8.
Jiang, Rilei, Shaohua Ge, Qin Wang, et al.. (2021). MiR-21-5p Induces Pyroptosis in Colorectal Cancer via TGFBI. Frontiers in Oncology. 10. 610545–610545. 43 indexed citations
9.
Jiang, Rilei, et al.. (2020). Equity and efficiency of health care resource allocation in Jiangsu Province, China. International Journal for Equity in Health. 19(1). 211–211. 80 indexed citations
10.
Hu, Cheng, Rilei Jiang, Ling Gu, et al.. (2019). Ophiopogonin-B Suppresses Epithelial-mesenchymal Transition in Human Lung Adenocarcinoma Cells via the Linc00668/miR-432-5p/EMT Axis. Journal of Cancer. 10(13). 2849–2856. 23 indexed citations
11.
12.
Jiang, Rilei, Cheng Hu, Qian Li, et al.. (2019). Sodium new houttuyfonate suppresses metastasis in NSCLC cells through the Linc00668/miR-147a/slug axis. Journal of Experimental & Clinical Cancer Research. 38(1). 155–155. 28 indexed citations
13.
Hu, Cheng, et al.. (2018). Exosome-related tumor microenvironment. Journal of Cancer. 9(17). 3084–3092. 60 indexed citations
14.
Chen, Meijuan, Cheng Hu, Yuanyuan Guo, et al.. (2018). Ophiopogonin B suppresses the metastasis and angiogenesis of A549 cells in�vitro and in�vivo by inhibiting the EphA2/Akt signaling pathway. Oncology Reports. 40(3). 1339–1347. 21 indexed citations
15.
Fengrong, Jiang, Rilei Jiang, Xiaojia Zhu, Xu Zhang, & Zhan Zhan. (2013). Genipin Inhibits TNF-α-Induced Vascular Smooth Muscle Cell Proliferation and Migration via Induction of HO-1. PLoS ONE. 8(8). e74826–e74826. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dongfeng Guo Breakdown of academic impact, for papers by Md Zakir Hossain Breakdown of academic impact, for papers by Maryam Radinmanesh Breakdown of academic impact, for papers by Xiaoyan Cheng Breakdown of academic impact, for papers by Jiayi Gu Breakdown of academic impact, for papers by Jie Ding Breakdown of academic impact, for papers by Yu He Breakdown of academic impact, for papers by Randy J. Levitt Breakdown of academic impact, for papers by Jianchao Liu
Rankless by CCL
2026